Simplex Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$14K | – | 10151 |
|
|
2023
Q2 | $14K | Sell |
1,000
-600
| -38% | -$8.59K | ﹤0.01% | 7128 |
|
|
2023
Q1 | $24K | Buy |
1,600
+500
| +45% | +$8.35K | ﹤0.01% | 6747 |
|
|
2022
Q4 | $18K | Buy |
+1,100
| New | +$17.9K | ﹤0.01% | 7004 |
|
|
2022
Q2 | – | Sell |
-1,200
| Closed | -$11K | – | 11402 |
|
|
2022
Q1 | $11K | Sell |
1,200
-9,000
| -88% | -$76.5K | ﹤0.01% | 8826 |
|
|
2021
Q4 | $99K | Buy |
10,200
+8,100
| +386% | +$152K | ﹤0.01% | 6268 |
|
|
2021
Q3 | $78K | Hold |
2,100
| – | – | ﹤0.01% | 6966 |
|
|
2021
Q2 | $76K | Buy |
2,100
+2,082
| +11,567% | +$80.6K | ﹤0.01% | 7124 |
|
|
2021
Q1 | $80K | Sell |
18
-9
| -33% | -$419 | ﹤0.01% | 6052 |
|
|
2020
Q4 | $154K | Buy |
27
+1
| +4% | +$59 | ﹤0.01% | 4957 |
|
|
2020
Q3 | $133K | Sell |
26
-42
| -62% | -$2.06K | ﹤0.01% | 4589 |
|
|
2020
Q2 | $406K | Buy |
68
+34
| +100% | +$1.82K | ﹤0.01% | 3165 |
|
|
2020
Q1 | $139K | Buy |
34
+10
| +42% | +$555 | ﹤0.01% | 4019 |
|
|
2019
Q4 | $149K | Buy |
24
+17
| +243% | +$808 | ﹤0.01% | 4076 |
|
|
2019
Q3 | $23K | Buy |
7
+6
| +600% | +$178 | ﹤0.01% | 5719 |
|
|
2019
Q2 | $2K | Buy |
+1
| New | +$23 | ﹤0.01% | 6793 |
|
Other funds holding DCPH
Simplex Trading's DCPH Position: Q2 2024 in Review
Simplex Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 519 shares — an estimated $8K sold.
Simplex Trading first reported a position in DCPH in Q3 2019 and held it in 12 quarters. The position peaked at $758K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Simplex Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Simplex Trading sold 519 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $8K.
- Simplex Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
- Simplex Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $758K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.